 | • レポートコード：QFJ1-5011 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、弁膜性心疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心臓カテーテル検査、心電図（ECG）、胸部X線、ストレス検査、その他）、用途別市場規模（病院 & クリニック、外科手術センター、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・弁膜性心疾患治療の市場動向 ・企業の競争状況、市場シェア ・弁膜性心疾患治療の種類別市場規模と予測2016-2027（心臓カテーテル検査、心電図（ECG）、胸部X線、ストレス検査、その他） ・弁膜性心疾患治療の用途別市場規模と予測2016-2027（病院 & クリニック、外科手術センター、研究所） ・弁膜性心疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・弁膜性心疾患治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・弁膜性心疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・弁膜性心疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・弁膜性心疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、B. Braun Melsungen AG、Boston Scientific Corp.、Medtronic、CryoLife Inc.、Edwards Lifesciences Corporation、LivaNova PLC、Neovasc Inc.、Micro Interventional Devices、Symetis SA、Jenavalve Technology、TTK Healthcare Limited、Colibri Heart Valve、Lepu Medical Technology Co.、Braile Biomédica） ・結論 |
Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.
Market Analysis and Insights: Global Valvular Heart Disease Treatment Market
The global Valvular Heart Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Valvular Heart Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Valvular Heart Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Valvular Heart Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Valvular Heart Disease Treatment market.
Global Valvular Heart Disease Treatment Scope and Market Size
Valvular Heart Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Valvular Heart Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cardiac Catheterization
Electrocardiogram (ECG)
Chest X-Ray
Stress Test
Others
Segment by Application
Hospital & Clinics
Ambulatory Surgical Centers
Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
B. Braun Melsungen AG
Boston Scientific Corp.
Medtronic
CryoLife Inc.
Edwards Lifesciences Corporation
LivaNova PLC
Neovasc Inc.
Micro Interventional Devices
Symetis SA
Jenavalve Technology
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology Co.
Braile Biomédica
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cardiac Catheterization
1.2.3 Electrocardiogram (ECG)
1.2.4 Chest X-Ray
1.2.5 Stress Test
1.2.6 Others
1.3 Market by Application
1.3.1 Global Valvular Heart Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Valvular Heart Disease Treatment Market Perspective (2016-2027)
2.2 Valvular Heart Disease Treatment Growth Trends by Regions
2.2.1 Valvular Heart Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Valvular Heart Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Valvular Heart Disease Treatment Industry Dynamic
2.3.1 Valvular Heart Disease Treatment Market Trends
2.3.2 Valvular Heart Disease Treatment Market Drivers
2.3.3 Valvular Heart Disease Treatment Market Challenges
2.3.4 Valvular Heart Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Valvular Heart Disease Treatment Players by Revenue
3.1.1 Global Top Valvular Heart Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Valvular Heart Disease Treatment Revenue
3.4 Global Valvular Heart Disease Treatment Market Concentration Ratio
3.4.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2020
3.5 Valvular Heart Disease Treatment Key Players Head office and Area Served
3.6 Key Players Valvular Heart Disease Treatment Product Solution and Service
3.7 Date of Enter into Valvular Heart Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Valvular Heart Disease Treatment Breakdown Data by Type
4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Valvular Heart Disease Treatment Breakdown Data by Application
5.1 Global Valvular Heart Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Valvular Heart Disease Treatment Market Size (2016-2027)
6.2 North America Valvular Heart Disease Treatment Market Size by Type
6.2.1 North America Valvular Heart Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Valvular Heart Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Valvular Heart Disease Treatment Market Size by Type (2016-2027)
6.3 North America Valvular Heart Disease Treatment Market Size by Application
6.3.1 North America Valvular Heart Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Valvular Heart Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Valvular Heart Disease Treatment Market Size by Application (2016-2027)
6.4 North America Valvular Heart Disease Treatment Market Size by Country
6.4.1 North America Valvular Heart Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Valvular Heart Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Valvular Heart Disease Treatment Market Size (2016-2027)
7.2 Europe Valvular Heart Disease Treatment Market Size by Type
7.2.1 Europe Valvular Heart Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Valvular Heart Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Valvular Heart Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Valvular Heart Disease Treatment Market Size by Application
7.3.1 Europe Valvular Heart Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Valvular Heart Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Valvular Heart Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Valvular Heart Disease Treatment Market Size by Country
7.4.1 Europe Valvular Heart Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Valvular Heart Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Valvular Heart Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Valvular Heart Disease Treatment Market Size (2016-2027)
9.2 Latin America Valvular Heart Disease Treatment Market Size by Type
9.2.1 Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Valvular Heart Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Valvular Heart Disease Treatment Market Size by Application
9.3.1 Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Valvular Heart Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Valvular Heart Disease Treatment Market Size by Country
9.4.1 Latin America Valvular Heart Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Valvular Heart Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Valvular Heart Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Details
11.2.2 B. Braun Melsungen AG Business Overview
11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction
11.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.2.5 B. Braun Melsungen AG Recent Development
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Details
11.3.2 Boston Scientific Corp. Business Overview
11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction
11.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.3.5 Boston Scientific Corp. Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Valvular Heart Disease Treatment Introduction
11.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.4.5 Medtronic Recent Development
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Details
11.5.2 CryoLife Inc. Business Overview
11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction
11.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.5.5 CryoLife Inc. Recent Development
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Details
11.6.2 Edwards Lifesciences Corporation Business Overview
11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction
11.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.6.5 Edwards Lifesciences Corporation Recent Development
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Details
11.7.2 LivaNova PLC Business Overview
11.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction
11.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.7.5 LivaNova PLC Recent Development
11.8 Neovasc Inc.
11.8.1 Neovasc Inc. Company Details
11.8.2 Neovasc Inc. Business Overview
11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction
11.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.8.5 Neovasc Inc. Recent Development
11.9 Micro Interventional Devices
11.9.1 Micro Interventional Devices Company Details
11.9.2 Micro Interventional Devices Business Overview
11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction
11.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.9.5 Micro Interventional Devices Recent Development
11.10 Symetis SA
11.10.1 Symetis SA Company Details
11.10.2 Symetis SA Business Overview
11.10.3 Symetis SA Valvular Heart Disease Treatment Introduction
11.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.10.5 Symetis SA Recent Development
11.11 Jenavalve Technology
11.11.1 Jenavalve Technology Company Details
11.11.2 Jenavalve Technology Business Overview
11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction
11.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.11.5 Jenavalve Technology Recent Development
11.12 TTK Healthcare Limited
11.12.1 TTK Healthcare Limited Company Details
11.12.2 TTK Healthcare Limited Business Overview
11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction
11.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.12.5 TTK Healthcare Limited Recent Development
11.13 Colibri Heart Valve
11.13.1 Colibri Heart Valve Company Details
11.13.2 Colibri Heart Valve Business Overview
11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction
11.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.13.5 Colibri Heart Valve Recent Development
11.14 Lepu Medical Technology Co.
11.14.1 Lepu Medical Technology Co. Company Details
11.14.2 Lepu Medical Technology Co. Business Overview
11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction
11.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.14.5 Lepu Medical Technology Co. Recent Development
11.15 Braile Biomédica
11.15.1 Braile Biomédica Company Details
11.15.2 Braile Biomédica Business Overview
11.15.3 Braile Biomédica Valvular Heart Disease Treatment Introduction
11.15.4 Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2016-2021)
11.15.5 Braile Biomédica Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cardiac Catheterization
Table 3. Key Players of Electrocardiogram (ECG)
Table 4. Key Players of Chest X-Ray
Table 5. Key Players of Stress Test
Table 6. Key Players of Others
Table 7. Global Valvular Heart Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Valvular Heart Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Valvular Heart Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Valvular Heart Disease Treatment Market Share by Regions (2016-2021)
Table 11. Global Valvular Heart Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Valvular Heart Disease Treatment Market Share by Regions (2022-2027)
Table 13. Valvular Heart Disease Treatment Market Trends
Table 14. Valvular Heart Disease Treatment Market Drivers
Table 15. Valvular Heart Disease Treatment Market Challenges
Table 16. Valvular Heart Disease Treatment Market Restraints
Table 17. Global Valvular Heart Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Valvular Heart Disease Treatment Market Share by Players (2016-2021)
Table 19. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2020)
Table 20. Ranking of Global Top Valvular Heart Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Valvular Heart Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Valvular Heart Disease Treatment Product Solution and Service
Table 24. Date of Enter into Valvular Heart Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Valvular Heart Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Valvular Heart Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Valvular Heart Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Valvular Heart Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Valvular Heart Disease Treatment Product
Table 67. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. B. Braun Melsungen AG Company Details
Table 70. B. Braun Melsungen AG Business Overview
Table 71. B. Braun Melsungen AG Valvular Heart Disease Treatment Product
Table 72. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 73. B. Braun Melsungen AG Recent Development
Table 74. Boston Scientific Corp. Company Details
Table 75. Boston Scientific Corp. Business Overview
Table 76. Boston Scientific Corp. Valvular Heart Disease Treatment Product
Table 77. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 78. Boston Scientific Corp. Recent Development
Table 79. Medtronic Company Details
Table 80. Medtronic Business Overview
Table 81. Medtronic Valvular Heart Disease Treatment Product
Table 82. Medtronic Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 83. Medtronic Recent Development
Table 84. CryoLife Inc. Company Details
Table 85. CryoLife Inc. Business Overview
Table 86. CryoLife Inc. Valvular Heart Disease Treatment Product
Table 87. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 88. CryoLife Inc. Recent Development
Table 89. Edwards Lifesciences Corporation Company Details
Table 90. Edwards Lifesciences Corporation Business Overview
Table 91. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product
Table 92. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 93. Edwards Lifesciences Corporation Recent Development
Table 94. LivaNova PLC Company Details
Table 95. LivaNova PLC Business Overview
Table 96. LivaNova PLC Valvular Heart Disease Treatment Product
Table 97. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 98. LivaNova PLC Recent Development
Table 99. Neovasc Inc. Company Details
Table 100. Neovasc Inc. Business Overview
Table 101. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 102. Neovasc Inc. Recent Development
Table 103. Micro Interventional Devices Company Details
Table 104. Micro Interventional Devices Business Overview
Table 105. Micro Interventional Devices Valvular Heart Disease Treatment Product
Table 106. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 107. Micro Interventional Devices Recent Development
Table 108. Symetis SA Company Details
Table 109. Symetis SA Business Overview
Table 110. Symetis SA Valvular Heart Disease Treatment Product
Table 111. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 112. Symetis SA Recent Development
Table 113. Jenavalve Technology Company Details
Table 114. Jenavalve Technology Business Overview
Table 115. Jenavalve Technology Valvular Heart Disease Treatment Product
Table 116. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 117. Jenavalve Technology Recent Development
Table 118. TTK Healthcare Limited Company Details
Table 119. TTK Healthcare Limited Business Overview
Table 120. TTK Healthcare Limited Valvular Heart Disease Treatment Product
Table 121. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 122. TTK Healthcare Limited Recent Development
Table 123. Colibri Heart Valve Company Details
Table 124. Colibri Heart Valve Business Overview
Table 125. Colibri Heart Valve Valvular Heart Disease Treatment Product
Table 126. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 127. Colibri Heart Valve Recent Development
Table 128. Lepu Medical Technology Co. Company Details
Table 129. Lepu Medical Technology Co. Business Overview
Table 130. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product
Table 131. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 132. Lepu Medical Technology Co. Recent Development
Table 133. Braile Biomédica Company Details
Table 134. Braile Biomédica Business Overview
Table 135. Braile Biomédica Valvular Heart Disease Treatment Product
Table 136. Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2016-2021) & (US$ Million)
Table 137. Braile Biomédica Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Valvular Heart Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cardiac Catheterization Features
Figure 3. Electrocardiogram (ECG) Features
Figure 4. Chest X-Ray Features
Figure 5. Stress Test Features
Figure 6. Others Features
Figure 7. Global Valvular Heart Disease Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital & Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Valvular Heart Disease Treatment Report Years Considered
Figure 12. Global Valvular Heart Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Valvular Heart Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Valvular Heart Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Valvular Heart Disease Treatment Market Share by Regions (2022-2027)
Figure 16. Global Valvular Heart Disease Treatment Market Share by Players in 2020
Figure 17. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2020
Figure 19. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Valvular Heart Disease Treatment Market Share by Type (2016-2027)
Figure 23. North America Valvular Heart Disease Treatment Market Share by Application (2016-2027)
Figure 24. North America Valvular Heart Disease Treatment Market Share by Country (2016-2027)
Figure 25. United States Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Valvular Heart Disease Treatment Market Share by Type (2016-2027)
Figure 29. Europe Valvular Heart Disease Treatment Market Share by Application (2016-2027)
Figure 30. Europe Valvular Heart Disease Treatment Market Share by Country (2016-2027)
Figure 31. Germany Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Valvular Heart Disease Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Valvular Heart Disease Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Valvular Heart Disease Treatment Market Share by Region (2016-2027)
Figure 41. China Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Valvular Heart Disease Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Valvular Heart Disease Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Valvular Heart Disease Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Valvular Heart Disease Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Valvular Heart Disease Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Valvular Heart Disease Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Valvular Heart Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 61. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 62. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 63. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 64. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 65. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 66. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 67. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 68. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 69. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 70. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 71. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 72. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 73. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 74. Braile Biomédica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の心臓カテーテル検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heart Catheterization Market The global Heart Catheterization market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…- 世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …
- 世界の心不全治療市場規模・現状・予測（2021年-2027年） The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people beca…
- 世界のリソソーム蓄積症治療市場規模・現状・予測（2021年-2027年） Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder. Market Analysis and Insights: Global Lysosomal Storage Disease Treatment Market The global Lysosoma…